Publication number: 20230228741
Abstract: A method for determining the health status of an elderly individual by testing the sample extracted from the individual for the presence of biomarkers, the bio markers being autoantibodies to antigens comprising MAPK13, CD96, FKBP3, PPM1A, PHLDA1, GLRX3, FEN1 and AURKA, wherein the antigens may further comprise one or more of UBE2I, AAK1, YARS, ASPSCR1, CASP10, FHOD2, TCL1A and MAP4, wherein PHLDA1 and CD96 correspond to healthy, AURKA, FEN1, CASP10 and AAK1 correspond to intermediate health, and UBE2I, YARS, ASPSCR1, FHOD2, TCL1A, MAP4, MAPK13, FKBP3, PPM1A and GLRX3 correspond to unhealthy.
Type:
Application
Filed:
September 23, 2020
Publication date:
July 20, 2023
Applicants:
Sengenics Corporation Pte Ltd, Agency for Science, Technology and Research
Inventors:
Jonathan Michael BLACKBURN, Arif ANWAR, Nurul H. RUTT, Anis LARBI, Olivier Nicolas Felix CEXUS, Bernett LEE, Jesus Felix Bayta VALENZUELA, Christopher MONTEROLA, Victor TONG